On Jun 23, 2021 Orum Therapeutics closed a Series B round and raised $54,000,000 from Atinum Investment, IMM Investment, KB Investment, KDB Capital, featuring lead investors IMM Investment.

About the company: Orum Therapeutics is located at South Korea, Asia. “Orum Therapeutics is combining the precision of antibodies with the power of targeted protein degraders to bring new medicines to patients with unmet medical needs. Orum (오름) means ‘ascent’ in Korean, climbing or moving upwards. Our vision is a world where no patient suffers from diseases caused by undruggable targets.”

Company website: www.orumrx.com